You are here: Home » PTI Stories » National » News
Business Standard

Eris Lifesciences IPO oversubscribed 1.14 times on last day

Press Trust of India  |  New Delhi 

The initial public offer of Eris Lifesciences was oversubscribed 1.14 times till early afternoon trade on the last day of bidding today.

The IPO, looking to raise Rs 1,741 crore, received bids for 1,82,02,296 against the total issue size of 1,59,48,750, data available with the till 1215 hours showed.



Eris Lifesciences last week mopped up Rs 779 crore from 21 anchor investors.

The price band for the share sale has been fixed at Rs 600-603. The offer comprises sale of 2.89 crore

The book running lead managers to the offer are Axis Capital, Citigroup and Credit Suisse Securities (India).

Eris Lifesciences is into manufacturing of branded pharmaceutical products in select therapeutic areas.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Eris Lifesciences IPO oversubscribed 1.14 times on last day

The initial public offer of Eris Lifesciences was oversubscribed 1.14 times till early afternoon trade on the last day of bidding today. The IPO, looking to raise Rs 1,741 crore, received bids for 1,82,02,296 shares against the total issue size of 1,59,48,750, data available with the NSE till 1215 hours showed. Eris Lifesciences last week mopped up Rs 779 crore from 21 anchor investors. The price band for the share sale has been fixed at Rs 600-603. The offer comprises sale of 2.89 crore shares. The book running lead managers to the offer are Axis Capital, Citigroup Global Markets India and Credit Suisse Securities (India). Eris Lifesciences is into manufacturing of branded pharmaceutical products in select therapeutic areas. The initial public offer of Eris Lifesciences was oversubscribed 1.14 times till early afternoon trade on the last day of bidding today.

The IPO, looking to raise Rs 1,741 crore, received bids for 1,82,02,296 against the total issue size of 1,59,48,750, data available with the till 1215 hours showed.

Eris Lifesciences last week mopped up Rs 779 crore from 21 anchor investors.

The price band for the share sale has been fixed at Rs 600-603. The offer comprises sale of 2.89 crore

The book running lead managers to the offer are Axis Capital, Citigroup and Credit Suisse Securities (India).

Eris Lifesciences is into manufacturing of branded pharmaceutical products in select therapeutic areas.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Eris Lifesciences IPO oversubscribed 1.14 times on last day

The initial public offer of Eris Lifesciences was oversubscribed 1.14 times till early afternoon trade on the last day of bidding today.

The IPO, looking to raise Rs 1,741 crore, received bids for 1,82,02,296 against the total issue size of 1,59,48,750, data available with the till 1215 hours showed.

Eris Lifesciences last week mopped up Rs 779 crore from 21 anchor investors.

The price band for the share sale has been fixed at Rs 600-603. The offer comprises sale of 2.89 crore

The book running lead managers to the offer are Axis Capital, Citigroup and Credit Suisse Securities (India).

Eris Lifesciences is into manufacturing of branded pharmaceutical products in select therapeutic areas.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22